Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump

21 Oct 2016

Abstract excerpt

Antibiotic resistance is a major threat to human welfare. Inhibitors of multidrug efflux pumps (EPIs) are promising alternative therapeutics that could revive activities of antibiotics and reduce bacterial virulence. Identification of new druggable sites for inhibition is critical for the development of effective EPIs, especially in light of constantly emerging resistance. Here, we describe EPIs that interact...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27768847
DOI: 10.1021/acsinfecdis.6b00167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux PumpPMID 27768847Read ↗

Efflux Pumps of Gram-Negative Bacteria, a New Target for New MoleculesSemantic proximity Read ↗

RND-type drug eﬄux pumps from Gram-negative bacteria: molecular mechanism and inhibitionSemantic proximity Read ↗

Conformational flexibility in the multidrug efflux system protein AcrA.Semantic proximity Read ↗

Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative BacteriaSemantic proximity Read ↗

Efflux Pumps: Their Role in Antibacterial Drug DiscoverySemantic proximity Read ↗

Co-development of efflux pump inhibitors with antibiotics on targeting structural and mutational aspects of AcrB subunit.Semantic proximity Read ↗

Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coliSemantic proximity Read ↗

AcrAB-TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanismSemantic proximity Read ↗

Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux PumpsSemantic proximity Read ↗

Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux PumpsSemantic proximity Read ↗

Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.Semantic proximity Read ↗

Bacterial Efflux Pump Modulators Prevent Bacterial Growth in Macrophages and Under Broth Conditions that Mimic the Host EnvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.